PepsiCo, Inc. vs 10X Genomics Inc — how do they compare? PepsiCo, Inc. trades at $135.65 (market cap $184.26B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: PepsiCo, Inc. is far larger — about 33.6× 10X Genomics Inc's market cap, and PepsiCo, Inc. pays a 4.39% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| PEP | TXG | |
|---|---|---|
Market Cap | $184.26B | $5.48B |
Sector | Consumer Staples | Health |
52-Week High | $170.44 | $47.20 |
52-Week Low | $134.98 | $11.34 |
Enterprise Value | $226.76B | $5.02B |
Dividend Yield | 4.39% | — |
Signals from Pluang's Aura AI — not financial advice
PepsiCo (PEP) trades at $134.98, down 0.35% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $93.93B in 2025 with a net income margin of 10.78%, and it has beaten EPS estimates in the last three quarters. Recent news highlights price cuts on snacks like Doritos after consumer pushback and the termination of a music festival sponsorship.
The outlook is mixed: analyst consensus is a buy with a $158.79 price target, but near-term risks include competitive pressures and execution of the North American turnaround. Earnings growth and margin expansion from cost initiatives remain key catalysts for upside, though high valuation ratios and debt levels warrant caution.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →